Spots Global Cancer Trial Database for Misoprostol for Reduction of Blood Loss During Fibroid Surgery
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Misoprostol for Reduction of Blood Loss During Fibroid Surgery
Official Title: Buccal Misoprostol Prior to Abdominal Myomectomy for Reduction of Intraoperative Blood Loss: A Randomized Placebo-Controlled Trial
Study ID: NCT02209545
Conditions
Study Description
Brief Summary: The aim of this research work is to assess the impact of a single preoperative dose of buccal misoprostol in reducing blood loss during abdominal fibroid surgery.
Detailed Description: This is a trial of women undergoing fibroid surgery at a university-affiliated tertiary care center. Eligible participants will be randomized to receive preoperative 400ucg buccal (under the tongue) misoprostol or placebo on the basis of total fibroid volume, location, parity. Intra-operative blood loss will be compared between groups.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Locations
Northwestern University, Prentice Women's Hospital, Chicago, Illinois, United States
Contact Details
Name: Magdy Milad, MD
Affiliation: Northwestern University, Northwestern Memorial Hopsital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
